Rocket Lab Above 200-Day EMA After $300M NASA Win

Rocket Lab Holdings (NASDAQ: RKLB) shares declined from a May 27 high of $151 to roughly $84 in recent weeks despite the company winning a $300 million NASA contract for two science missions, PolSIR and TSIS-2.

The NASA award covers the Polarized Submillimeter Ice-cloud Radiometer (PolSIR) and the Total and Spectral Solar Irradiance Sensor-2 (TSIS-2) missions and is valued at $300 million. The company has a mix of launch and spacecraft services on its manifest tied to those programs.

In its most recent quarter Rocket Lab reported $200 million in revenue, a 63.5% increase from the year-earlier period. The company lists a revenue backlog of more than $2.2 billion across more than 70 missions. Most backlog bookings are for the Electron small-launch vehicle; demand has also increased for the HASTE smallsat bus and for the larger Neutron rocket. Rocket Lab booked five Neutron launches in the most recent quarter and its manifest extends into the end of the decade.

Consensus analyst estimates project roughly $915 million in revenue for the current year, a year-over-year gain near 52%, and about $1.29 billion the following year, a gain near 41%. The shares trade at a forward price-to-sales ratio near 53.

Technically, the share price remains above its 200-day exponential moving average and sits along an ascending trendline that connects lows dating to November. Chart analysis places a cluster of support near the Murrey Math “Strong, Pivot, Reverse” level at about $75. If the price holds above that level, a near-term retest of the $100 area is a technical possibility; a decisive move below $75 would remove that scenario.

Rocket Lab’s stock had rallied to a record $151 earlier in the year, a rise of roughly 3,700% from its 2014 low and a market capitalization near $82 billion at the peak. The recent retreat coincided with weakness across the space sector, where other listed companies have also pulled back and where one large private company’s shares are more than 30% below post-IPO highs. Rocket Lab’s inclusion in a blue-chip index required ETF and mutual fund managers to add the stock, producing a brief price lift before later selling activity.

The company’s financial results, backlog figures and the NASA award are published metrics. The stock’s price action and technical levels are observable data points that market participants can track.